Dry Eye Disease
📧 Sign up to get email alerts when something new happens for Dry Eye Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of tavilermide ophthalmic solution for dry eye disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study) [Phase 3]
Phase 3 PROTEGO-1 trial comparing cenegermin (Oxervate) to vehicle in severe Sjögren's Dry Eye Disease has completed and results have been p…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Evaluation of the Effectiveness of a Community Health Management Program for Dry Eye Disease in Middle-Aged and Elderly Individuals [NA]
The document reports a clinical trial evaluating a community health management program for dry eye disease in middle-aged and elderly indivi…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia
A completed clinical trial evaluated the safety and efficacy of calcitonin gene-related peptide (CGRP) antagonists for dry eye disease and a…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Tanfanercept (HL036) for dry eye disease has been suspended.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Study of OT202 in Treating Moderate to Severe Dry Eye [Phase 2]
A Phase 2 clinical trial evaluating OT202 for moderate to severe dry eye has completed.
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Electroacupuncture for Mild-to-moderate Dry Eye [NA]
A clinical trial sponsored by the Shanghai Institute of Acupuncture, Moxibustion and Meridian is recruiting to evaluate electroacupuncture f…
-
FDA approval · 2024-05-28FDA Approved: VEVYE — Supplemental Application (Harrow Eye, LLC)
FDA approved a supplemental application for VEVYE (cyclosporine ophthalmic solution) from Harrow Eye, LLC. The approval pertains to the opht…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: A Randomized Study of Smile Exercise for Dry Eye [NA]
A randomized study evaluated smile exercise for dry eye; the trial sponsored by Zhongshan Ophthalmic Center at Sun Yat-sen University has co…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface [Phase 4]
Phase 4 clinical trial comparing benzalkonium chloride–preserved eye drops with preservative-free eye drops to evaluate effects on the ocula…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Effect of Periorbital Massage on Dry Eye Disease [NA]
A clinical trial evaluating periorbital massage for dry eye disease is sponsored by Superior University and is currently active but not recr…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis [Phase 4]
Phase 4 clinical trial evaluating IKERVIS eye drops administered once daily for quality of vision in dry eye disease patients with severe ke…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: CEQUA for Sjogren's Syndrome Dry Eye [Phase 4]
Phase 4 clinical trial update for CEQUA in Sjogren's syndrome–associated dry eye has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers [Phase 4]
Phase 4 clinical trial evaluating Miebo (Perfluorohexyloctane) eyedrops in habitual contact lens wearers for dry eye conditions has been com…
-
FDA approval · 2024-04-04FDA Approved: XIIDRA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for XIIDRA (lifitegrast) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Vizol S Lipid Balance Efficacy and Safety Study in Patients With Dry Eye [Phase 3]
Phase 3 trial update for Vizol S assessing efficacy and safety in dry eye disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Study of ST-100 as Treatment for Dry Eye Disease [Phase 2]
Phase 2 clinical trial of ST-100 for dry eye disease has completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye [Phase 2]
Phase 2 trial evaluating the safety and efficacy of VSJ-110 versus placebo in dry eye disease.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome [Phase 3]
Phase 3 clinical trial update for tivanisiran in dry eye due to Sjögren's syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Safety Study of Tivanisiran to Treat Dry Eye [Phase 3]
Phase 3 safety study of tivanisiran for dry eye disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease [Phase 2]
Phase 2 trial evaluating OK-101 for efficacy and safety in dry eye disease has been completed.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Effect of Cequa™ in Subjects With Dry Eye Disease [Phase 4]
Phase 4 trial update investigating Cequa in subjects with dry eye disease; results posted.
-
FDA approval · 2024-02-02FDA Approved: TYRVAYA — Supplemental Application (Oyster Point Pharma, Inc.)
FDA approved a supplemental application for TYRVAYA (varenicline) from Oyster Point Pharma, expanding the regulatory approval.
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease [Phase 4]
A Phase 4 clinical trial evaluating hyaluronic acid–containing artificial tears for post-cataract surgery-related dry eye disease has comple…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED) [Phase 3]
A Phase 3 clinical trial update on ST-100 (Vezocolmitide) ophthalmic solution for dry eye disease, reporting on its safety and efficacy.